TNF-blocker therapy for Legionella
Kneitz, C.
Zeitschrift für Rheumatologie 74(4): 282-283
2015
ISSN/ISBN: 0340-1855 PMID: 26158131 Document Number: 683495
Document emailed within 1 workday
Related Documents
Furberg, C.D.; Byington, R.P. 1983: What do subgroup analyses reveal about differential response to beta-blocker therapy? The Beta-Blocker Heart Attack Trial experience Circulation 67(6 Part 2): I98-101Kawanishi, D.T.; Reid, C.L.; Gonzales, A.; O'Rourke, R.A.; Rahimtoola, S.H. 1989: Response of blood pressure, cardiac output, peripheral resistance, and exercise performance to substitution of calcium blocker for beta-blocker plus thiazide diuretic therapy in patients with both systemic hypertension and mild stable angina Circulation 80(6 Suppl): Iv162-Iv170
Dournon, E.; Desplaces, N.; Colignon, A. 1985: Legionella infections in the Paris area. Predominance of serogroup 1 Legionella pneumophila infections Presse Medicale 14(18): 1040
Böhm, M. 2003: Therapy of heart failure. Which patients does the AT1 blocker help? MMW Fortschritte der Medizin 145(38): 8
Böhm, M. 2003: Therapy of heart failure. which patients does the AT1 blocker help? MMW Fortschritte der Medizin 145(38): 8
Christandl, B. 1981: Therapy of coronary disease with the beta-blocker betapressin Fortschritte der Medizin 99(36): 1473-1476
Perry, A.; Sparling, J.D.; Pennington, M. 2005: Bullous pemphigoid following therapy with an oral beta-blocker Journal of Drugs in Dermatology: Jdd 4(6): 746-748
Tölle, T.R.; Ceballos-Baumann, A.O.; Straube, A. 2002: From neuromuscular blocker to analgesic. what is the value of botulinum toxin in pain therapy? MMW Fortschritte der Medizin 144(6): 35-37
Passamonti, E.; Pirelli, S. 2003: Beta-blocker therapy and risk reduction in non-cardiac surgery Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 4(2): 96-101
Dennis, K.E.; Froman, D.; Morrison, A.S.; Holmes, K.D.; Howes, D.G. 1991: Beta-blocker therapy: identification and management of side effects Heart and Lung: the Journal of Critical Care 20(5 Part 1): 459-463
Neimark, A.I.; Davydov, A.V.; Aliev, R.T. 2018: The effects of combination therapy with 5-reductase inhibitor and -blocker on the prognosis of BPH Urologiia 2: 62-66
Goldstein, S. 2002: Benefits of beta-blocker therapy for heart failure: weighing the evidence Archives of Internal Medicine 162(6): 641-648
Rohatgi, S.; Bhattacharya, R.; Das Gupta, S. 1993: Efficacy of calcium channel blocker as an adjunct in therapy of organophosphate poisoning Indian Journal of Physiology and Pharmacology 37(3): 255-256
Dominiak, P. 1993: Doxazosin. a postsynaptic alpha 1-adrenergic receptor blocker in therapy of hypertension Der Internist 34(7): 682-687
Tongia, S.K.; Vijayvargiya, R.; Pande, S. 1982: H1-blocker blocks ganglion blocker Indian Journal of Physiology and Pharmacology 26(1): 99-100
Meshkinpour, H. 1995: Esophageal aperistalsis and gastroesophageal reflux disorder: return of peristalsis after H2-blocker therapy American Journal of Gastroenterology 90(6): 910-914
2003: AT1 blocker therapy of hypertension in seniors. Added protection for cerebral blood vessels? MMWFortschrittederMedizin 145(1-2): 53
Einecke, D. 2000: Short-term intervention in ulcer and reflux. new acid blocker halves duration of therapy MMW Fortschritte der Medizin 142(26-27): 50-51
Takayama, T.; Arakawa, I.; Kakihara, H.; Tachibana, K.; Ozono, S. 2012: Pharmacoeconomic evaluation of combination therapy with dutasteride and α1 blocker for treatment of benign prostatic hyperplasia in Japan Hinyokika Kiyo. Acta Urologica Japonica 58(2): 61-69
Zhuk, A.E.; Broun, L.M.; Mendelevich, L.A. 1986: Course of concomitant diseases in ischemic heart disease patients on long-term beta-blocker therapy Klinicheskaia Meditsina 64(2): 95-97